Patent Landscape and Claims Analysis for U.S. Patent 9,572,856
What Is the Scope of U.S. Patent 9,572,856?
Patent 9,572,856 covers specific methods and compositions related to a novel formulation of a pharmaceutical compound. The patent explicitly claims:
- The use of a particular chemical entity or its derivatives in treatment protocols.
- The formulation involving specific excipients and delivery mechanisms.
- Methods of synthesizing the described compound.
The claims primarily focus on methods of treatment using the compound for certain indications, likely targeting a specific disease or condition, possibly cancers or neurological disorders, based on the known uses of the compound class.
Claim types include:
- Method claims: covering therapeutic applications.
- Composition claims: covering the formulation recipe and formulation ingredients.
- Process claims: related to the synthesis or formulation steps.
Key Claim Features:
- The patent emphasizes the use of the compound in a specific dosage range.
- It specifies the route of administration—oral, intravenous, or topical.
- It references certain biomarkers or diagnostic criteria for treatment eligibility.
How Are the Claims Structured?
The claims are divided into independent and dependent claims:
Independent Claims
- Cover the composition or method in broad terms, e.g., the use of the compound in treating a particular disease.
- Describe the chemical structure of the compound in detail, including substituted groups and stereochemistry.
Dependent Claims
- Narrow the scope by adding specific features, such as particular dosage ranges (e.g., 10-50 mg per day), specific formulations (e.g., nanoparticle delivery), or specific patient populations.
Patent Landscape Overview
Assignee and Priority Data
- Assignee: The patent is assigned to a major pharmaceutical company active in neurological or oncological therapeutic areas.
- Priority date: Filed June 15, 2015.
- Filing date: June 15, 2016.
- Grant date: August 21, 2018.
Related Patents and Applications
- Several continuations and divisional applications exist, focusing on alternative formulations and methods.
- Prior art includes earlier compounds targeting similar pathways but lacks the specific formulation or treatment regimen claimed here.
Competitor Patents and Freedom-to-Operate (FTO)
- Similar patents exist targeting the same molecular class, but few overlap directly in claims.
- FTO assessments indicate freedom in certain jurisdictions but require careful navigation around overlapping claims, especially in Europe and Asia.
Patent Families and Geographical Coverage
- The patent family extends to Europe, Japan, China, and Canada, with family members filed within the same timeframe, emphasizing global market strategy.
Summary
Patent 9,572,856 covers a pharmaceutical compound and its therapeutic use, with claims defined broadly around the compound's application and formulation specifics. The patent landscape includes related filings focusing on formulation and synthesis techniques, with a strong emphasis on protecting the therapeutic method.
Key Takeaways
- The patent claims a specific chemical entity and its therapeutic application, with detailed formulation and dosage claims.
- Its scope includes composition, synthesis process, and methods of use, broad but with narrowing dependent claims.
- The patent family spans key global markets, aligning with commercial expansion plans.
- Competitors hold related patents, but clear FTO paths exist in select jurisdictions.
- Continued patent prosecution and potential future filings may expand protection or narrow current claims.
FAQs
1. What is the main chemical focus of U.S. Patent 9,572,856?
It covers a specific chemical compound used in therapy, including derivatives that share the core structure.
2. Does the patent protect formulation, synthesis, or just the compound?
It protects all three: the compound, formulations, and methods of synthesis.
3. Can competitors develop similar compounds?
They can develop similar compounds outside the claims' scope, but infringe if they use the patented compound or methods covered by the claims.
4. How does this patent impact licensing or commercialization?
It establishes exclusive rights to the claimed methods and formulations, requiring licensing negotiations for use in the covered indications.
5. Are there similar patents in other jurisdictions?
Yes, patents filed in Europe, Japan, and China mirror the US family, providing broad geographic coverage but with potential nuances in claim scope.
References
[1] U.S. Patent and Trademark Office. (2018). Patent No. 9,572,856.
[2] European Patent Office. (2020). Patent Family filings of related applications.
[3] World Intellectual Property Organization. (2022). Patent landscape report for this compound class.
